Young‐Ik Son
성균관대학교 의과대학 · 의학
Young-Ik Son 교수의 연구실은 뇌신경외과 및 두경부 종양 영상의학을 중심으로, 뇌신경종양과 두경부 암의 영상진단 및 정밀 예측 모델 개발에 주력하고 있습니다. 특히 림프절 전이나 치료 반응을 고도로 예측하기 위해 인공지능 기반의 생존 예측 모델을 개발하며, 임상적 요소와 영상 소견을 융합한 개인 맞춤형 진료를 추구합니다. 뇌신경종양의 영상 특징 분석과 함께, 뇌간, 척수, 뇌신경 등 복잡한 해부학적 영역의 종양 진단에 특화된 영상 기반 진단 기법을 지속적으로 발전시키고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
The prevalence of LLNM was high although the prognostic impact is unknown. The significant risk factors for LLNM were not much different from known risk factors for CLNM.
Speech after SCPL was not better than speech after TL-VP and was widely variable. The configuration of the neoglottis during phonation in the SCPL group was also variable. We believe that some technical refinement during the operation could improve speech outcome after SCPL.
Basal cell adenomas of the parotid gland present as small well-marginated tumors and appear as masses with central large cysts or solid masses with microcysts on CT and MR imaging scans. Basal cell adenomas of the parotid gland had at least 2 different enhancement patterns on the 2-phase helical CT scans, and the enhancement patterns and imaging architecture were related to the histologic subtype of the tumors.
Most recent survival prediction has been based on TNM staging, which does not provide individualized information. However, clinical factors including performance status, age, sex, and smoking might influence survival. Therefore, we used artificial intelligence (AI) to analyze various clinical factors to precisely predict the survival of patients with larynx squamous cell carcinoma (LSCC). We included patients with LSCC (N = 1026) who received definitive treatment from 2002 to 2020. Age, sex, smo
The SUVs from FDG PET imaging alone cannot predict the pathologic extrathyroid invasion in patients with TPMC. However, the ultrasonographic findings, such as tumor site, provide better information about the extrathyroid invasion of TPMC tumor foci.
Among cytokines applied for immunotherapy of cancer, one of the most successful approaches to date involves systemic delivery of high-dose interleukin (IL)-2. However, the clinical utility of high-dose IL-2 has been limited by significant adverse effects, including vascular leak syndrome. Given this limitation, many attempts to decrease the dosage of IL-2 while maintaining its antitumor therapeutic effects are being made. In this study, the authors observed that combined use of IL-18 and low-dos
BRAF mutation of PTC may have differential predictive values for LN metastasis, according to tumor size.
Adoptive transfer of dendritic cells pulsed with apoptotic tumor cells as a source of tumor antigens, can elicit effective antitumor responses in the poorly immunogenic SCC model when combined with interleukin-2.
4 Laryngoscope, 2020.
